Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial.
Bonneville-Levard A, Frappaz D, Tredan O, Lavergne E, Corset V, Agrapart V, Chabaud S, Pissaloux D, Wang Q, Attignon V, Cartalat S, Ducray F, Thomas-Maisonneuve L, Honnorat J, Meyronet D, Taillandier L, Blonski M, Viari A, Baudet C, Sohier E, Lantuejoul S, Paindavoine S, Treilleux I, Rodriguez C, Pérol D, Blay JY. Bonneville-Levard A, et al. Among authors: frappaz d. Med Oncol. 2021 Nov 5;39(1):4. doi: 10.1007/s12032-021-01536-4. Med Oncol. 2021. PMID: 34739635
Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial.
Trédan O, Wang Q, Pissaloux D, Cassier P, de la Fouchardière A, Fayette J, Desseigne F, Ray-Coquard I, de la Fouchardière C, Frappaz D, Heudel PE, Bonneville-Levard A, Fléchon A, Sarabi M, Guibert P, Bachelot T, Pérol M, You B, Bonnin N, Collard O, Leyronnas C, Attignon V, Baudet C, Sohier E, Villemin JP, Viari A, Boyault S, Lantuejoul S, Paindavoine S, Treillleux I, Rodriguez C, Agrapart V, Corset V, Garin G, Chabaud S, Pérol D, Blay JY; ProfiLER investigators. Trédan O, et al. Among authors: frappaz d. Ann Oncol. 2019 May 1;30(5):757-765. doi: 10.1093/annonc/mdz080. Ann Oncol. 2019. PMID: 30865223 Free article.
Tumor Molecular Profiling: Pediatric Results of the ProfiLER Study.
Benezech S, Saintigny P, Attignon V, Pissaloux D, Paindavoine S, Faure-Conter C, Corradini N, Marec-Berard P, Bergeron C, Cassier P, Eberst L, Dufresne A, Wang Q, Agrapart V, De La Fouchardière A, Perol D, Garin G, Corset V, Ben Abdesselem L, Chabaud S, Tredan O, Blay JY, Frappaz D. Benezech S, et al. Among authors: frappaz d. JCO Precis Oncol. 2020 Nov;4:785-795. doi: 10.1200/PO.20.00023. JCO Precis Oncol. 2020. PMID: 35050753
Characteristics of cerebellar glioblastomas in adults.
Picart T, Barritault M, Berthillier J, Meyronet D, Vasiljevic A, Frappaz D, Honnorat J, Jouanneau E, Poncet D, Ducray F, Guyotat J. Picart T, et al. Among authors: frappaz d. J Neurooncol. 2018 Feb;136(3):555-563. doi: 10.1007/s11060-017-2682-7. Epub 2017 Dec 1. J Neurooncol. 2018. PMID: 29196927
MEVITEM-a phase I/II trial of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation.
Frappaz D, Barritault M, Montané L, Laigle-Donadey F, Chinot O, Le Rhun E, Bonneville-Levard A, Hottinger AF, Meyronnet D, Bidaux AS, Garin G, Pérol D. Frappaz D, et al. Neuro Oncol. 2021 Nov 2;23(11):1949-1960. doi: 10.1093/neuonc/noab087. Neuro Oncol. 2021. PMID: 33825892 Free PMC article. Clinical Trial.
Are molecular subgroups of medulloblastomas really prognostic?
Frappaz D, Faure-Conter C, Meyronet D, Levard-Bonneville A, Beuriat PA, Sunyach MP, Barritault M. Frappaz D, et al. Curr Opin Neurol. 2018 Dec;31(6):747-751. doi: 10.1097/WCO.0000000000000626. Curr Opin Neurol. 2018. PMID: 30300240 Review.
[Adolescent and Young Adults (AYAS) brain tumor national Web conference. On behalf of ANOCEF, GO-AJA and SFCE societies].
Frappaz D, Sunyach MP, Le Rhun E, Blonski M, Laurence V, Bonneville Levard A, Loiseau H, Meyronnet D, Callies A, Laigle-Donadey F, Faure Conter C; au nom de l’ANOCEF, GO-AJA, de la SFCE. Frappaz D, et al. Bull Cancer. 2016 Dec;103(12):1050-1056. doi: 10.1016/j.bulcan.2016.10.010. Epub 2016 Nov 17. Bull Cancer. 2016. PMID: 27866682 French.
310 results